Apheresis Equipment Analysis 2024


The Global Apheresis Equipment Market is projected to reach $8.29 billion by 2028, from a value of $3.94 billion in 2022, by registering a CAGR of 13.2% during the forecast period 2022-2028

SKU: ER1088 Category:
© Epson Research 2021
Share this infographic on
Published Year:
Forecast period:
Report Coverage:

Market Trends and analysis of the crucial market segments across North America, Europe, Asia Pacific and Rest of the World.

Report Format:

5 User License

$ 5,500

  • Access to Five users
  • Print upto 5 copies
  • PDF & Excel Formats

Corporate User License

$ 7,000

  • Unlimited users within company
  • Free Yearly update
  • PDF & Excel Formats

The Global Apheresis Equipment Market is projected to reach $8.29 billion by 2028, from a value of $3.94 billion in 2022, by registering a CAGR of 13.2% during the forecast period. Larger adoption of disposable apheresis kits arising from the high incidence rates of hospital acquired infections, growing prevalence of blood related disorders, presence of favorable reimbursement policies, and rise in demand for source plasma from biopharmaceutical companies are the major factors propelling the growth of the market. However, lack of blood donors, risks associated with apheresis devices and high cost of apheresis devices & therapeutic apheresis procedures are hampering market growth. Moreover, increasing investments from government bodies and apheresis for leukemia and paediatric patients are creating ample opportunities across the globe.

Recent Developments

In October 2021, Terumo Blood and Cell Technologies expanded its production capacity by opening a new manufacturing facility in Costa Rica worth $60 million USD. The Costa Rica plant will help to expand the production of Spectra Optia Apheresis System besides other products and support its global supply chain spanning 130 countries.

In July 2020, Haemonetics Corporation announced that it had entered into an agreement with Abénex to sell its full-owned subsidiary Inlog Holdings France SAS to the latter company. The transaction is projected to close by the end of the Third quarter of 2020.

In August 2017, Fresenius Medical Care (Germany) acquired NxStage Medical, Inc. (US). This acquisition enabled Fresenius Medical Care to further expand its presence in the renal care and critical care area.

In April 2017, B. Braun announced strategic collaboration with Christie Medical Holdings, Inc. This collaboration aimed to specifically deliver patients and health care professionals with a seamless result for refining peripheral IV access.

In January 2017, Hemacare Corporation entered into a strategic alliance with One Blood Inc., a blood center based in Florida. This partnership proved beneficial for the company growth and helped the firm to develop more apheresis related products.

Competitive Landscape

Terumo Corporation (Terumo BCT), B. Braun Melsungen AG, Medica S.p.A., Asahi Kasei Corporation, Baxter International, Kaneka Corporation, Fresenius SE & Co. KGAA (Fresenius Kabi AG), Otsuka Holdings Co. Ltd, Haemonetics Corporation, Kawasumi Laboratories, Cerus Corporation, Nikkiso Co. Ltd, Mallinckrodt PLC, Macopharma SA, and HemaCare Corporation are some of the major players in the global Apheresis Equipment market.


1 Summary
2 Market Overview
2.1 Abstract
2.2 Research Sources
2.3 Research Findings
2.4 Assumptions
3 Market Dynamics
3.1 Drivers & Opportunities
3.2 Restraints & Threats
3.3 Regulatory Affairs
3.4 Supplychain Analysis
3.5 PORTERS Analysis
4 Competitive Landscape
5 Apheresis Equipment Market by Procedure
5.1 Erythrocytapheresis (Red Blood Cells)
5.2 Extracorporeal Immunoadsorption (ECI)
5.3 Leukapheresis
5.4 Photopheresis
5.5 Low-Density Lipoprotein (LDL) Apheresis
5.6 Plasmapheresis (Plasma)
5.7 Plateletpheresis (Platelets)
5.8 Therapeutic Cytapheresis Equipment
5.9 Other Procedures
5.9.1 Lipidpheresis
5.9.2 Lymphopheresis
6 Apheresis Equipment Market by Product
6.1 Apheresis Machines/Devices
6.2 Disposable Apheresis Kits
6.3 Plasma and Component Separator
7 Apheresis Equipment Market by Technology
7.1 Membrane Filtration
7.2 Centrifugation
7.2.1 Continuous Flow Centrifugation
7.2.2 Intermittent Flow Centrifugation
8 Apheresis Equipment Market by Distribution Channel
8.1 Direct
8.2 Retail
9 Apheresis Equipment Market by Application
9.1 Blood Collection
9.2 Therapeutic Purpose/Treatment
9.2.1 Autoimmune Disorders
9.2.2 Cardiovascular Disorders
9.2.3 Hematology
9.2.4 Neurological Disorders
9.2.5 Renal Disorders
9.2.6 Metabolic Disorders
10 Apheresis Equipment Market by End User
10.1 Ambulatory Surgical Centers
10.2 Blood Banks/Blood Donation Centers
10.3 Dialysis Centres
10.4 Hospitals & Clinics
10.5 Diagnostic Centers
11 Apheresis Equipment Market by Regions
11.1 North America
11.2 Europe
11.3 Asia Pacific
11.4 Rest of the World
12 Company Profiles
12.1 Terumo Corporation (Terumo BCT)
12.2 B. Braun Melsungen AG
12.3 Medica S.p.A.
12.4 Asahi Kasei Corporation
12.5 Baxter International
12.6 Kaneka Corporation
12.7 Fresenius SE & Co. KGAA (Fresenius Kabi AG)
12.8 Otsuka Holdings Co. Ltd
12.9 Haemonetics Corporation
12.10 Kawasumi Laboratories
12.11 Cerus Corporation
12.12 Nikkiso Co. Ltd
12.13 Mallinckrodt PLC
12.14 Macopharma SA
12.15 HemaCare Corporation